Best Dermatology Telehealth Platforms for Health Brands

Which platforms belong on the initial shortlist?

Vendor descriptions below reflect official pages reviewed as of October 22, 2026. These are candidates for a scoped evaluation, not a claim that every listed vendor offers every treatment or state. The right-hand column is our procurement analysis.

What kind of dermatology business are you actually buying infrastructure for?

A dermatology brand can mean very different operations. One company may focus on a narrowly defined prescription pathway, another on ongoing skin-health consultations, and another on a hybrid service that routes some patients to an in-person practice. Those models require different clinical scope, patient expectations and workflows. A platform should be evaluated against the model you plan to operate, not against a generic skin-care landing page.

Write down the supported pathway and its limits with the responsible clinical team. Identify what information clinicians need, what may be assessed remotely, and when the patient should be directed elsewhere. The brand owner can define positioning and service experience, but the clinical team decides the medical boundaries. Avoid treating a long medication menu as a substitute for that work.

Then describe the commercial experience honestly. A customer may be buying an assessment, ongoing access, a subscription or a product after an appropriate prescription. Those are different transactions. The checkout should explain which one is being purchased and what happens if the clinical evaluation does not support the expected next step. Our dermatology launch guide helps convert the concept into an operational brief.

What should you look for in image intake and clinical messaging?

Ask the vendor to demonstrate image submission on a typical phone. Look at instructions, file handling and the process for asking the patient for a better image or additional history. A successful upload is not the same as a clinically useful submission. The software should make it easy for the responsible professional to request what is missing without forcing the patient to restart the entire journey.

Test an incomplete submission rather than only the vendor’s ideal demo. Can the team distinguish a technical upload problem from a clinical request? Can support see enough status to help without being asked to interpret the image? Does the patient know whether the case is waiting for them or for the clinical team? These are practical questions that often decide how much manual work the operation creates.

Also review how messages and images remain attached to the correct record through follow-up. Ask what export options exist, how access is controlled and whether staff actions are recorded. Use synthetic records and non-patient demonstration images during procurement. You are evaluating the workflow and ownership of the next action, not inviting a vendor sales team to diagnose a real person.

How do you handle a case that does not fit the online pathway?

The most important demo may be the one that does not lead to a sale. Ask the clinical team to describe, at a process level, how a patient is informed when the service cannot meet their needs remotely. The platform should support a clear outcome, appropriate instructions from the responsible clinician and a commercial resolution consistent with the advertised policy.

Do not reduce every unsuccessful conversion to a checkout problem. Some patients should not proceed through the selected program. A useful operating dashboard distinguishes incomplete intake, technical failure, a patient decision to stop and a clinical outcome that requires a different path. That separation lets the brand improve usability without pressuring clinicians to change medical decisions.

Define what support can say, who responds to clinical questions and how an unresolved referral or follow-up is tracked. If the business also has physical offices, demonstrate the handoff into that environment. For a digital-only brand, establish the limits of the service plainly. Our white-label telehealth guide explains why a complete operating model includes exceptions as well as the standard flow.

How should treatment, product and marketing information stay aligned?

Keep the public offering connected to the current clinical and pharmacy scope. If a formulation, shipping route or supported state changes, the storefront should not continue advertising a pathway that the operation cannot deliver. Assign a responsible person to coordinate catalog updates with the clinical and fulfillment partners, and define who approves the medical wording.

Pay special attention to before-and-after imagery, testimonials and timelines. They can communicate an implied result even when the page avoids a direct promise. The FTC’s health-products guidance explains the need for truthful, supported health claims. In a procurement review, ask how the vendor helps your team maintain approved content and which marketing responsibilities remain with the brand.

If the proposed offering includes compounded medication, do not describe pharmacy registration as product approval. The FDA states that compounded drugs are not FDA-approved. Review the exact product, fulfillment and disclosure requirements with the appropriate partners. The platform’s job is to support accurate presentation and execution, not to make an unavailable product appropriate by putting it in a beautiful checkout.

What costs belong in a dermatology-platform comparison?

Request prices for the actual workflow: initial assessment, follow-up, messaging, platform access, prescription coordination, medication, shipping, payment processing and support. Determine which charges occur when an evaluation is completed without a prescription. Ask how refunds, replacement shipments and additional clinical reviews are handled. The quoted monthly subscription alone is not a complete cost of serving a patient.

Model a small set of explicit scenarios. One patient submits everything needed and completes the planned pathway. Another needs a second image submission. A third needs a clinical response after fulfillment. Compare how each vendor supports those journeys and how your own staff would participate. The additional work matters even when it does not appear as a separate vendor line item.

TEHR uses a flat platform subscription plus a flat transaction fee with 0% revenue share. Review the service and pricing scope and use the TEHR pricing calculator for your assumptions. An existing practice buying software and a new brand buying coordinated infrastructure are not purchasing the same thing. Normalize proposals before declaring one cheaper.

What should you preserve if you migrate an existing dermatology brand?

Inventory the information that supports the existing patient relationship: encounters, submitted images, message history, consent records, current medication information and future service obligations. Ask what can be transferred as structured data and what will remain available as attached files. A spreadsheet of names and email addresses is not equivalent to a usable clinical history.

Rehearse the migration with a small, authorized sample and have the appropriate staff review the receiving view. Check whether images remain associated with the correct encounter, whether messages keep their chronology, and whether support can distinguish old orders from new activity. Clinical review requirements belong to the receiving clinical organization; imported history is not an automatic new prescription.

Use the migration checklist for cutover planning and patient communications. Choose TEHR if you want a coordinated branded platform around independent care and operations. Choose a narrower software or integration model when your current organization already supplies the other capabilities. Our sourced platform comparisons help turn that choice into specific questions about the work each partner will own.

Bring the people who will own the service into the final review: a brand operator, the clinical lead, the implementation owner and the person responsible for patient support. Ask each to identify the unresolved handoffs in the demonstrated workflow. Record those items in the launch scope with an accountable owner, rather than leaving them as informal sales-call promises.

What else should you know?